PubMed

Targets for intervention in dyslipidemia in diabetes.

Tomkin GH.

Diabetes Care. 2008 Feb;31 Suppl 2:S241-8. Review.PMID: 18227492 [PubMed - indexed for MEDLINE]Related articlesFree article

Optimal management of combined dyslipidemia: what have we behind statins monotherapy?

Tenenbaum A, Fisman EZ, Motro M, Adler Y.

Adv Cardiol. 2008;45:127-53. Review.PMID: 18230960 [PubMed - indexed for MEDLINE]Related articles

Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann-Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein.

Lally S, Tan CY, Owens D, Tomkin GH.

Diabetologia. 2006 May;49(5):1008-16. Epub 2006 Mar 4.PMID: 16518588 [PubMed - indexed for MEDLINE]Related articles

Treatment of diabetic dyslipoproteinemia.

Steinmetz A.

Exp Clin Endocrinol Diabetes. 2003 Aug;111(5):239-45. Review.PMID: 12951627 [PubMed - indexed for MEDLINE]Related articles

The treatment of dyslipidemia--what's left in the pipeline?

Rau O, Zettl H, Popescu L, Steinhilber D, Schubert-Zsilavecz M.

ChemMedChem. 2008 Feb;3(2):206-21. Review.PMID: 17963209 [PubMed - indexed for MEDLINE]Related articles

The intestine as a regulator of cholesterol homeostasis in diabetes.

Tomkin GH.

Atheroscler Suppl. 2008 Sep;9(2):27-32. Epub 2008 Aug 6. Review.PMID: 18693145 [PubMed - indexed for MEDLINE]Related articles

Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes.

Phillips C, Bennett A, Anderton K, Owens D, Collins P, White D, Tomkin GH.

Metabolism. 2002 Jul;51(7):847-52.PMID: 12077729 [PubMed - indexed for MEDLINE]Related articles

Genes that affect cholesterol synthesis, cholesterol absorption, and chylomicron assembly: the relationship between the liver and intestine in control and streptozotosin diabetic rats.

Lally S, Owens D, Tomkin GH.

Metabolism. 2007 Mar;56(3):430-8.PMID: 17292734 [PubMed - indexed for MEDLINE]Related articles

[Pharmacological therapy of obesity]

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian. PMID: 18773755 [PubMed - indexed for MEDLINE]Related articles

Novel agents to manage dyslipidemias and impact atherosclerosis.

Nachimuthu S, Raggi P.

Cardiovasc Hematol Disord Drug Targets. 2006 Sep;6(3):209-17. Review.PMID: 17017903 [PubMed - indexed for MEDLINE]Related articles

Targeting cardiovascular risk in patients with diabetes: management of dyslipidemia.

Ali YS, Linton MF, Fazio S.

Curr Opin Endocrinol Diabetes Obes. 2008 Apr;15(2):142-6. Review.PMID: 18316949 [PubMed - indexed for MEDLINE]Related articles

How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?

Rizzo M, Berneis K, Carmina E, Rini GB.

Am J Obstet Gynecol. 2008 Jan;198(1):28.e1-5. Review.PMID: 18166299 [PubMed - indexed for MEDLINE]Related articles

The different effect of pioglitazone as compared to insulin on expression of hepatic and intestinal genes regulating post-prandial lipoproteins in diabetes.

Lally S, Owens D, Tomkin GH.

Atherosclerosis. 2007 Aug;193(2):343-51. Epub 2006 Nov 15.PMID: 17109865 [PubMed - indexed for MEDLINE]Related articles

Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.

Adiels M, Olofsson SO, Taskinen MR, Borén J.

Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1225-36. Review.PMID: 18565848 [PubMed - indexed for MEDLINE]Related articlesFree article

Lipid-lowering therapy in patients with type 2 diabetes: the case for early intervention.

Steinmetz A.

Diabetes Metab Res Rev. 2008 May-Jun;24(4):286-93. Review.PMID: 18273835 [PubMed - indexed for MEDLINE]Related articles

Comprehensive lipid management versus aggressive low-density lipoprotein lowering to reduce cardiovascular risk.

Knopp RH, Paramsothy P, Atkinson B, Dowdy A.

Am J Cardiol. 2008 Apr 17;101(8A):48B-57B. Review.PMID: 18375242 [PubMed - indexed for MEDLINE]Related articles

Controversies in dyslipidemias: atheroprevention in diabetes and insulin resistance.

Brinton EA.

Ann N Y Acad Sci. 2005 Dec;1055:159-78. Review.PMID: 16387723 [PubMed - indexed for MEDLINE]Related articles

Diabetic dyslipidemia and atherosclerosis: evidence from clinical trials.

Farmer JA.

Curr Atheroscler Rep. 2007 Aug;9(2):162-8.PMID: 17877926 [PubMed - indexed for MEDLINE]Related articles

Management of dyslipidemia in the metabolic syndrome.

Tan KC.

Cardiovasc Hematol Disord Drug Targets. 2007 Jun;7(2):99-108. Review.PMID: 17584044 [PubMed - indexed for MEDLINE]Related articles

Effects of adding prescription omega-3 acid ethyl esters to simvastatin (20 mg/day) on lipids and lipoprotein particles in men and women with mixed dyslipidemia.

Maki KC, McKenney JM, Reeves MS, Lubin BC, Dicklin MR.

Am J Cardiol. 2008 Aug 15;102(4):429-33. Epub 2008 May 22. Erratum in: Am J Cardiol. 2008 Nov 15;102(10):1425. PMID: 18678300 [PubMed - indexed for MEDLINE]Related articles